Quantbot Technologies LP Genmab A/S Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $694,184 - $966,518	20,538 New	20,538 $870,000
Q2 2021 Aug 12, 2021	SELL	$32.88 - $44.57 $28,868 - $39,132	-878 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$30.92 - $44.4 $6,864 - $9,856	-222 Reduced 20.18%	878 $28,000
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $30,293 - $36,684	900 Added 450.0%	1,100 $44,000
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $6,614 - $7,736	200 New	200 $7,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.